Wamlox 5 mg/160 mg filmom obložene tablete
Name | Wamlox 5 mg/160 mg filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-895152202 |
Active Substance | amlodipinbesilat, valsartan |
Composition | svaka filmom obložena tableta sadrži 5 mg amlodipina (u obliku amlodipinbesilata) i 160 mg valsartana. |
Pharmaceutical Form | filmom obložena tableta |
Packaging [MA Number for Packaging] | 10 tableta u blisteru, u kutiji [HR-H-895152202-01] 14 tableta u blisteru, u kutiji [HR-H-895152202-02] 28 tableta u blisteru, u kutiji [HR-H-895152202-03] 30 tableta u blisteru, u kutiji [HR-H-895152202-04] 56 tableta u blisteru, u kutiji [HR-H-895152202-05] 60 tableta u blisteru, u kutiji [HR-H-895152202-06] 84 tablete u blisteru, u kutiji [HR-H-895152202-07] 90 tableta u blisteru, u kutiji [HR-H-895152202-08] 100 tableta u blisteru, u kutiji [HR-H-895152202-09] 98 tableta u blisteru, u kutiji [HR-H-895152202-10] |
Manufacturer | Krka d.d., Novo mesto, Novo Mesto, Slovenija TAD Pharma Gmbh, Cuxhaven, Njemačka Krka - farma d.o.o., Jastrebarsko, Hrvatska |
Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
Marketing Authorisation Date | 01.02.2021 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/20-02/41 |
Registration Number | 381-12-01/38-21-02 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | C09DB01 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |